High-dose medroxyprogesterone acetate for the treatment of dysfunctional uterine bleeding in 24 adolescents

M. Feridun Aksu, F Aksu, R Madazli, Rıza Madazlı, E. Budak, Erdal Budak, I Cepni, İsmail Çepni, A Benian, Ali Benian
The Australian & New Zealand journal of obstetrics & gynaecology · 1997 · vol. 37(2) , pp. 228–231 · doi:10.1111/j.1479-828x.1997.tb02260.x · PMID:9222474 · W2014666046
Other OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

High-dose medroxyprogesterone acetate effectively stopped or reduced severe dysfunctional uterine bleeding in 24 hospitalized adolescents without underlying hematological disorders.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The objective of the study was to evaluate the effectiveness of high-dose oral medroxyprogesterone acetate therapy in the management of excessive dysfunctional uterine bleeding in adolescents. The study group consisted of 24 adolescents who were hospitalized with the diagnosis of excessive uterine bleeding and anaemia. Oral medroxyprogesterone acetate tablets were administered at a total dose of 60-120 mg during the first day of admission and 20 mg per day for the following 10 days. The blood loss was reduced to acceptable levels in all patients, and actually stopped in 6 (25%) within the first 24 hours of the treatment; bleeding ceased in 29.2%, 20.8% and 25% on the second, third and fourth days respectively. Significant correlation was identified between the initial haemoglobin concentration and the time required for cessation of bleeding (r2 = 0.5, p = 0.001). Rapid saturation of the endometrium with progestogens seems to be an highly effective mode of treatment for excessive dysfunctional uterine bleeding in adolescents.

My notes (saved in your browser only)

MeSH descriptors

Medroxyprogesterone Acetate Menstruation Disturbances Progesterone Congeners Adolescent Anemia Anemia Female Humans Medroxyprogesterone Acetate Medroxyprogesterone Acetate Menstruation Disturbances Menstruation Disturbances Progesterone Congeners Progesterone Congeners Treatment Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (13)

Cited by (6)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T22:00:22.376048+00:00
License: CC0 · commercial use OK